Miglietta A, Bocca C, Gadoni E, Gabriel L, Rampa A, Bisi A, Valenti P, Da Re P
Department of Experimental Medicine and Oncology, University of Torino, Italy.
Anticancer Drug Des. 1996 Jan;11(1):35-48.
Geiparvarin is an antiproliferative compound whose mechanism of action has not yet been identified. We have investigated the biochemical action on purified microtubular protein, as well as on tubulin, of geiparvarin and of some derivatives resulting from its conjugation with two synthetic oestrogens, diethylstilboestrol and meso-hexoestrol, in comparison with the antimicrotubular action of the reference oestrogens. Geiparvarin and derivatives did not inhibit colchicine binding to tubulin nor did they significantly influence GTP-induced polymerization. On the contrary, they effectively counteracted the stimulating effect of taxol on microtubule formation, both in the presence and in the absence of microtubule-associated proteins. A competitive inhibition mechanism at the taxol binding site of tubulin may thus be proposed to explain the antimicrotubular action of geiparvarin.
格帕伐林是一种增殖抑制性化合物,其作用机制尚未明确。我们研究了格帕伐林及其与两种合成雌激素己烯雌酚和中己烯雌酚结合产生的一些衍生物对纯化微管蛋白以及微管蛋白的生化作用,并与参考雌激素的抗微管作用进行了比较。格帕伐林及其衍生物既不抑制秋水仙碱与微管蛋白的结合,也不会显著影响鸟苷三磷酸(GTP)诱导的聚合反应。相反,无论有无微管相关蛋白,它们都能有效对抗紫杉醇对微管形成的刺激作用。因此,可能存在一种在微管蛋白的紫杉醇结合位点的竞争性抑制机制来解释格帕伐林的抗微管作用。